Browse by category

GE HealthCare and Novo Nordisk to collaborate on peripheral focused ultrasound for T2DM and obesity

GE HealthCare and Novo Nordisk are collaborating to further advance the clinical and product development of peripheral focused ultrasound...

First commercial use of Levita Magnetics’ MARS Surgical System

Levita Magnetics has announced the world's first commercial use of its MARS platform. The first commercial use, which took place in...

FDA clears GE HealthCare’s Allia IGS Pulse next generation of image-guided systems

GE HealthCare has gained FDA 510(k) clearance of the Allia IGS Pulse - the latest addition to the company’s image guided system (IGS)...

Novo Nordisk to end semaglutide kidney study early due to strong efficacy signals

Novo Nordisk is ending its Phase III FLOW trial ahead of schedule after an interim analysis of the kidney outcomes study of semaglutide...

Allurion completes AUDACITY trial enrolment for Allurion Balloon

Allurion Technologies has completed patient enrolment in its AUDACITY trial, a randomised, pivotal controlled trial designed to support...

Clinical trial of MBX 1416 for Post-Bariatric Hypoglycemia begins

The first participant has been dosed in MBX Biosciences’ Phase 1/2 clinical trial of MBX 1416, the company’s long-acting glucagon-like...

Phase III studies to investigate survodutide for people living with obesity and overweight

Boehringer Ingelheim and Zealand Pharma have initiated three Phase III trials investigating survodutide (also known as BI 456906) for...

First patient treated with SiPore21 for sustained diabetes and obesity control

The first patient has been treated with Sigrid Therapeutics’ SiPore21, an innovative medical device designed for sustained diabetes and...

European Medicines Agency to discuss anaesthesia risk for weight-loss drugs

The European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...

ReShape Lifesciences signs license agreement with Biorad Medisys for Obalon Gastric Balloon

ReShape Lifesciences has signed an exclusive, royalty-bearing license agreement with Biorad Medysis (Biorad) to manufacture,...

Verge Genomics reveals VRG201 as its candidate for long-term weight management and metabolic homeostasis

11 minutes ago

Structure Therapeutics selects oral small molecule amylin receptor agonist ACCG-2671 for obesity treatment

39 minutes ago

Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler

2 days ago

Weekly Digest